IGC Pharma GAAP EPS of -$0.02 in-line, revenue of $0.19M misses by $0.13M
Source: SeekingAlpha
2025-11-17 08:45:15 ET
More on IGC Pharma
- Seeking Alpha’s Quant Rating on IGC Pharma
- Historical earnings data for IGC Pharma
- Financial information for IGC Pharma
Read the full article on Seeking Alpha
For further details see:
IGC Pharma GAAP EPS of -$0.02 in-line, revenue of $0.19M misses by $0.13M
India Globalization Capital Inc.
NASDAQ: IGC
IGC Trading
1.71% G/L:
$0.2909 Last:
41,140 Volume:
$0.2899 Open:
IGC Latest News
February 26, 2026 08:30:00 am
IGC Pharma Files Utility Patent Applications Covering AI-Based Data Harmonization Architecture Supporting Alzheimer's Research
February 24, 2026 08:30:00 am
IGC Pharma Notes Updated Research Coverage from Ascendiant Capital Markets
February 23, 2026 08:30:00 am
IGC Pharma Adds Visionary Investigators Network as Clinical Site to Phase 2 CALMA Trial
February 17, 2026 08:30:00 am
IGC Pharma Secures North American Composition Protection for IGC-AD1 as Phase 2 CALMA Enrollment Advances
